Ulf Norming

1.4k total citations
44 papers, 1.1k citations indexed

About

Ulf Norming is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Ulf Norming has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 11 papers in Oncology. Recurrent topics in Ulf Norming's work include Bladder and Urothelial Cancer Treatments (19 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Prostate Cancer Treatment and Research (16 papers). Ulf Norming is often cited by papers focused on Bladder and Urothelial Cancer Treatments (19 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Prostate Cancer Treatment and Research (16 papers). Ulf Norming collaborates with scholars based in Sweden, United States and Finland. Ulf Norming's co-authors include Ove Gustafsson, Oskar Gustafsson, Magnus Törnblom, Hans Wijkström, C. R. Nyman, Claes R. Nyman, Bernhard Tribukait, Per Larsson, Jan Adolfsson and Anders Kjellman and has published in prestigious journals such as International Journal of Molecular Sciences, The Journal of Urology and International Journal of Cancer.

In The Last Decade

Ulf Norming

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulf Norming Sweden 19 521 489 335 193 135 44 1.1k
Gustavo de la Roza United States 15 705 1.4× 232 0.5× 283 0.8× 261 1.4× 106 0.8× 39 1.1k
Hedy Mameghan Australia 20 602 1.2× 415 0.8× 254 0.8× 143 0.7× 62 0.5× 54 1.2k
Nancy B. Davis United States 16 372 0.7× 220 0.4× 472 1.4× 297 1.5× 175 1.3× 61 989
David S. Yee United States 24 878 1.7× 486 1.0× 204 0.6× 400 2.1× 119 0.9× 44 1.4k
Delphine Amsellem‐Ouazana France 19 568 1.1× 394 0.8× 158 0.5× 553 2.9× 325 2.4× 42 1.4k
Philip H. Kim United States 15 383 0.7× 475 1.0× 207 0.6× 281 1.5× 113 0.8× 30 969
Darrel Drachenberg Canada 19 773 1.5× 677 1.4× 378 1.1× 438 2.3× 213 1.6× 99 1.5k
Ricardo Sánchez‐Ortiz United States 18 571 1.1× 506 1.0× 234 0.7× 269 1.4× 134 1.0× 34 1.0k
Andreas Reissigl Austria 22 1.0k 2.0× 336 0.7× 238 0.7× 227 1.2× 101 0.7× 56 1.4k
Göran Ahlgren Sweden 18 943 1.8× 194 0.4× 170 0.5× 174 0.9× 135 1.0× 45 1.2k

Countries citing papers authored by Ulf Norming

Since Specialization
Citations

This map shows the geographic impact of Ulf Norming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Norming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Norming more than expected).

Fields of papers citing papers by Ulf Norming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Norming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Norming. The network helps show where Ulf Norming may publish in the future.

Co-authorship network of co-authors of Ulf Norming

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Norming. A scholar is included among the top collaborators of Ulf Norming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Norming. Ulf Norming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tribukait, Bernhard, et al.. (2023). Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer. International Journal of Molecular Sciences. 24(6). 5160–5160. 4 indexed citations
2.
Thellenberg‐Karlsson, Camilla, Egils Vjaters, Teuvo L.J. Tammela, et al.. (2022). A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases. European Journal of Cancer. 181. 198–207. 5 indexed citations
3.
Kjellman, Anders, Olof Akre, Oskar Gustafsson, et al.. (2010). Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening. Journal of Internal Medicine. 269(3). 299–305. 31 indexed citations
4.
Kjellman, Anders, Olof Akre, Ulf Norming, Magnus Törnblom, & Ove Gustafsson. (2007). Dihydrotestosterone Levels and Survival in Screening-Detected Prostate Cancer: A 15-yr Follow-up Study. European Urology. 53(1). 106–111. 14 indexed citations
5.
Törnblom, Magnus, Stefan Franzén, Ove Gustafsson, et al.. (2003). Lead time associated with screening for prostate cancer. International Journal of Cancer. 108(1). 122–129. 69 indexed citations
6.
Seddighzadeh, Maria, Gunnar Steineck, Per Larsson, et al.. (2002). Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms. International Journal of Cancer. 99(5). 721–726. 27 indexed citations
7.
Törnblom, Magnus, Ulf Norming, C. Becker, Hans Lilja, & Oskar Gustafsson. (2001). Variation in percentage‐free prostate‐specific antigen (PSA) with prostate volume, age and total PSA level. British Journal of Urology. 87(7). 638–642. 8 indexed citations
8.
Wada, Takashi, Jari Louhelainen, K. Hemminki, et al.. (2001). The prevalence of loss of heterozygosity in chromosome 3, including FHIT , in bladder cancer, using the fluorescent multiplex polymerase chain reaction. British Journal of Urology. 87(9). 876–881. 7 indexed citations
9.
10.
Larsson, Per, Ulf Norming, Magnus Törnblom, & Oskar Gustafsson. (1999). Antibiotic prophylaxis for prostate biopsy: benefits and costs. Prostate Cancer and Prostatic Diseases. 2(2). 88–90. 17 indexed citations
11.
Schröder, Fritz H., Ulf Norming, Christer Busch, et al.. (1997). Phase II studies on prostate cancer. Urology. 49(4). 3–14. 15 indexed citations
12.
Gustafsson, Oskar, et al.. (1996). Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population. British Journal of Urology. 77(3). 433–440. 36 indexed citations
13.
14.
Norming, Ulf, Thomas Ebert, R. F. Mattrey, et al.. (1994). Imaging in the diagnosis and assessment of prognosis in localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.. PubMed. 162. 89–106; discussion 115. 3 indexed citations
15.
Agurell, Eva, Ronggui Li, Ulf Rannug, et al.. (1992). Detection of DNA alterations in human bladder tumors by DNA fingerprint analyses. Cancer Genetics and Cytogenetics. 61(1). 53–60. 8 indexed citations
16.
Gustafsson, Ove, et al.. (1992). Diagnostic Methods in the Detection of Prostate Cancer: A Study of a Randomly Selected Population of 2,400 Men. The Journal of Urology. 148(6). 1827–1831. 72 indexed citations
17.
Goldman, Sven, Håkan Arvidsson, Ulf Norming, et al.. (1991). Transrectal ultrasound and computed tomography in preoperative staging of lower rectal adenocarcinoma. Abdominal Imaging. 16(1). 259–263. 53 indexed citations
18.
Goldman, Sven, Ulf Norming, C. Svensson, & Bengt Glimelius. (1991). Transanorectal ultrasonography in the staging of anal epidermoid carcinoma. International Journal of Colorectal Disease. 6(3). 152–157. 32 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gustavo de la Roza Breakdown of academic impact, for papers by Hedy Mameghan Breakdown of academic impact, for papers by Nancy B. Davis Breakdown of academic impact, for papers by David S. Yee Breakdown of academic impact, for papers by Delphine Amsellem‐Ouazana Breakdown of academic impact, for papers by Philip H. Kim Breakdown of academic impact, for papers by Darrel Drachenberg Breakdown of academic impact, for papers by Ricardo Sánchez‐Ortiz Breakdown of academic impact, for papers by Andreas Reissigl Breakdown of academic impact, for papers by Göran Ahlgren
Rankless by CCL
2026